Finland’s flu vaccination programme is facing delays because of global vaccine supply problems, with several regional healthcare authorities postponing the start of their campaigns after this year’s vaccine production was held up.
Finland has received around one million doses so far, while another 800,000 are still expected to arrive. The delays have affected vaccination schedules in several regions, including Kymenlaakso, Satakunta and Ostrobothnia.
The Finnish Institute for Health and Welfare (THL) says the problem extends beyond Finland, affecting countries across Europe and other parts of the world. Mia Kontio of THL said this year’s production has been delayed partly because the World Health Organization (WHO) decided on the composition of the seasonal flu vaccine later than usual.
Another factor is that all three components of this year’s vaccine have been changed, adding to the time needed for production. Vaccine manufacturers update the formulation each season to improve protection against the influenza viruses expected to circulate. According to THL, the viruses have changed considerably since the previous flu season, making the updated composition particularly important.
Despite the disruption, Finland is in a relatively favourable position compared with some other European countries. Kontio said more than half of Finland’s expected vaccine supply has already arrived, while some countries in Europe are not expected to begin their vaccination campaigns until late November.
Finland usually starts its seasonal flu vaccinations early, but the delayed deliveries do not necessarily mean people will miss their opportunity to get vaccinated before the virus becomes more widespread. Kontio said November and the period before Christmas still provide time for people to receive their shots.
Influenza activity can begin before the main seasonal peak, but the number of cases typically rises after the new year in Finland. Although some infections have already been detected, Kontio said the main flu season generally begins later.
Once additional vaccine doses arrive, priority will be given to groups eligible for publicly recommended vaccinations. These include people aged 65 and over, children under seven, pregnant women and people whose health conditions put them at increased risk of severe influenza.
The timing of individual vaccination appointments will depend on vaccine availability and regional healthcare arrangements. People who are eligible for vaccination should check announcements from their local healthcare provider for the latest information on appointment dates and access to doses.
